Ablation Devices Market - By Technology (Radiofrequency Devices, Laser/Light Ablation, Ultrasound Devices, Cryoablation Devices), By Application (Cardiology, Oncology, Ophthalmology, Gynecology, Urology, Cosmetic Surgery), By End-use (Hospitals, Clinics)

Ablation Devices Market - By Technology (Radiofrequency Devices, Laser/Light Ablation, Ultrasound Devices, Cryoablation Devices), By Application (Cardiology, Oncology, Ophthalmology, Gynecology, Urology, Cosmetic Surgery), By End-use (Hospitals, Clinics) & Global Forecast, 2023 - 2032

Ablation Devices Market is estimated to grow considerably during 2023-2032 owing to the constant technological innovations in the industry to offer enhanced precision and better outcomes. In 2023, I-VASC announced the 1st clinical use of VELEX, the Empty Vein Ablation technology device for chronic venous insufficiency treatment.

These conglomerates are also investing in research and development activities for new product development and launches, thus positively expanding the product availability ratio. For instance, in February 2023, regulatory approval was granted for two of Abbott's electrophysiological products in Europe and the U.S. for treating patients with irregular cardiac rhythms like atrial fibrillation, Abbott's Sensor Enabled TactiFlex Ablation Catheter, an ablation catheter with an adaptable tip and contact force sensing, received the CE mark (AFib).

Also, according to the company, the TactiFlex Ablation Catheter SE can give high-power ablation treatment while more readily adjusting to the heart tissue. It has been demonstrated to shorten operation times and patient radiation exposure compared to traditional power ablation.

Overall, the ablation device industry is segmented in terms of technology, application, end-use and region.

Based on technology, the laser/light ablation segment is anticipated to be valued at over USD 2.1 billion by 2032. The constantly growing geriatric population base in developed and developing nations is expected to push the demand for laser/light ablation devices. In addition, key advantages linked with using laser ablation devices, such as high efficacy and safety, will also drive the segmental growth.

By application, the ophthalmology segment will depict over 9% CAGR during the estimated timeframe. Constant technological developments and budding adoption of advanced devices and well-equipped facilities that offer treatment for a wide range of ophthalmic diseases will drive the segment expansion between 2023-2032.

Considering the end-use, the others segment will grow considerably during the forecast period. Independent catheterization laboratories, physician's offices, multispecialty centers, and ablation centers are covered under the other segment. Increasing demand for multispecialty centers owing to their provision to offer specialized treatment for various medical conditions and superior quality of medical care will help the segment gain momentum through 2032 end.

Regionally, the Europe ablation device industry will be valued at over USD 5.5 billion by 2032. An increasing geriatric population base that is more susceptible to chronic diseases will stimulate the demand for ablation devices across the region. In addition, rising disposable income and high adoption of innovative technologies will further drive the European ablation devices market growth over the estimated timeframe.